/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Michael T. Schweizer

Fred Hutch Cancer Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

373

Papers

7.0K

Citations

42

h-index

98

i10-index

Michael T. Schweizer is an academic researcher from Fred Hutch Cancer Center. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Cancer Genomics and Diagnostics & Radiopharmaceutical Chemistry and Applications. The author has an h-index of 42, co-authored 318 publications.

ORCID: 0000-0002-5510-0661

Research Topics

Prostate Cancer Treatment and Research Cancer Genomics and Diagnostics Radiopharmaceutical Chemistry and Applications Prostate Cancer Diagnosis and Treatment Cancer Immunotherapy and Biomarkers

Papers by this author

works

Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

2019 · Journal of Clinical Investigation · 439 citations

https://doi.org/10.1172/jci128212

Mark P. Labrecque Ilsa M. Coleman Lisha G. Brown Lawrence D. True

A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer

2020 · Clinical Cancer Research · 126 citations

https://doi.org/10.1158/1078-0432.ccr-20-1707

Rahul Aggarwal Michael T. Schweizer David M. Nanus Allan J. Pantuck

Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer

2020 · Clinical Cancer Research · 83 citations

https://doi.org/10.1158/1078-0432.ccr-20-3396

Diana C. DeLucia Thomas M. Cardillo Lisa S. Ang Mark P. Labrecque

A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts

2020 · European Urology · 81 citations

https://doi.org/10.1016/j.eururo.2020.06.042

Mark C. Markowski Hao Wang Rana Sullivan Irina Rifkind

Persistent androgen receptor addiction in castration-resistant prostate cancer

2015 · Journal of Hematology & Oncology · 71 citations

https://doi.org/10.1186/s13045-015-0225-2

Michael T. Schweizer Evan Y. Yu

Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer

2023 · Clinical Genitourinary Cancer · 53 citations

https://doi.org/10.1016/j.clgc.2023.02.010

Emerson A. Lim Michael T. Schweizer Kim N.Rahul Aggarwal

Research topics

topics

Prostate Cancer Treatment and Research

Cancer Genomics and Diagnostics

Radiopharmaceutical Chemistry and Applications

Prostate Cancer Diagnosis and Treatment

Cancer Immunotherapy and Biomarkers

Chat about Author

Papers

Chat

Click to start Chat